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a b s t r a c t
Vaccinia virus contains 200 genes classiﬁed temporally as early, intermediate or late. We analyzed
53 intermediate promoters to determine whether any have dual late promoter activity. Our strategy
involved (i) construction of a cell line that stably expressed the three late transcription factors,
(ii) infection with a vaccinia virus mutant that expresses RNA polymerase but neither intermediate
nor late transcription factors, and (iii) transfection with plasmids containing a luciferase reporter
regulated by an intermediate promoter. After conﬁrming the speciﬁcity of the system for late promoters,
we found that many intermediate promoters had late promoter activity, the strength of which correlated
with a TAAAT at the initiator site and T-content from positions 12 to 8 of the coding strand.
In contrast, intermediate promoter activity correlated with the A-content from positions 22 to 14. The
sequence correlations were conﬁrmed by altering the speciﬁcities of strict intermediate and late promoters.
Published by Elsevier Inc.
Introduction
Poxviruses comprise a large family of DNA viruses that are noted
for their medical importance, usefulness as vaccine vectors and ability
to replicate entirely in the cytoplasm (Moss, 2013). Replication outside
of the nucleus is attributed in large part to poxvirus-encoded proteins
for genome replication and transcription. Gene expression is tempo-
rally programmed to occur in three consecutive stages: early, inter-
mediate and late (Baldick and Moss, 1993). Transcription is mediated
by a multisubunit DNA-dependent RNA polymerase and stage-speciﬁc
transcription factors that recognize cognate promoters (Moss, 2013).
Although characterized primarily for vaccinia virus (VACV), the
transcription system is conserved in all chordopoxviruses. Early genes
are transcribed with the aid of proteins that are synthesized late in
infection and packaged within infectious virus particles (Broyles and
Fesler, 1990; Broyles et al., 1988; Gershon and Moss, 1990). Inter-
mediate and late genes are transcribed following genome replication
and require the successive synthesis of intermediate and late tran-
scription factors, encoded by early and intermediate genes, respec-
tively (Keck et al., 1990; Sanz and Moss, 1999). Roles for speciﬁc
cellular proteins in intermediate and late gene expression have also
been reported (Katsafanas andMoss, 2004; Knutson et al., 2006, 2009;
Rosales et al., 1994; Wright et al., 2001).
VACV genes that are expressed early are readily recognized by their
transcription in the presence of inhibitors of protein and DNA
synthesis. Based on these criteria, we classiﬁed the VACV transcripts
for 118 open reading frames (ORFs) as early and 93 as post-replicative
(Yang et al., 2010). Discriminating between intermediate post-
replicative and late post-replicative transcripts is difﬁcult because of
their nearly concurrent synthesis and read-through of neighboring
genes. The most satisfactory method has been to infect cells with
VACV in the presence of an inhibitor of DNA replication, transfect
candidate intermediate and late genes, and monitor protein synthesis.
Only the intermediate genes are expressed because their transcription
factors are products of early genes whereas late transcription factors
are not made in the absence of DNA replication. Based on this
criterion, we identiﬁed 53 intermediate and 38 late genes (Yang
et al., 2011b). However, for technical reasons gene designations have
been based on a triage system. Thus, genes have been designated early
even though they might also be expressed at intermediate or late
stages. Similarly, genes have been designated intermediate even if they
might also be expressed late. Indeed, analyses of individual genes have
indicated the existence of tandem early and post-replicative promoters
(Cochran et al., 1985; Rosel et al., 1986; Vos and Stunnenberg, 1988)
and others have been artiﬁcially constructed (Baldick and Moss, 1993).
Identifying multistage promoters may help to better understand
poxvirus replication and their use may improve expression vectors.
Here we show that many intermediate promoters also have substan-
tial late promoter activity.
Results
Strategy to selectively express late genes
During VACV infection the transcription of intermediate genes
must precede the transcription of late genes because the late
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
0042-6822/$ - see front matter Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.virol.2013.09.007
n Corresponding author. Fax: þ1 301 480 1147.
E-mail address: bmoss@nih.gov (B. Moss).
Virology 447 (2013) 213–220
transcription factors are themselves products of intermediate genes.
However, in order to distinguish potential dual intermediate/late
promoters from intermediate-only promoters we needed a way to
selectively prevent intermediate promoter activity while allowing late
promoter activity. Our plan was to (i) construct a cell line that stably
expresses late transcription factors, (ii) infect such cells with a VACV
mutant that is unable to express intermediate or late transcription
factors but will express the viral RNA polymerase, and (iii) transfect
the cells with a plasmid containing a luciferase (LUC) reporter gene
regulated by the putative intermediate/late or intermediate-only
promoter (Fig. 1A). Only plasmids with a late promoter element
should express LUC. We already had the VACV intermediate-speciﬁc
transcription factor deletion mutants vA8Δ and vA23Δ, which are
propagated in the cell line RK13-A8/A23 that expresses the two
intermediate transcription factors (Warren et al., 2012). However, we
still needed a cell line that expresses the three late transcription
factors encoded by the G8R, A1L and A2L ORFs (Keck et al., 1990).
To express G8R, A1L and A2L ORFs in similar amounts in the same
cell, we made a tricistronic vector containing the three ORFs separated
by picornavirus 2A-like CHYSEL peptide sequences that mediate
co-translational separation of the nascent chains (de Felipe and
Ryan, 2004; Doronina et al., 2008). A Flag-tag was appended to the
C-terminus of the A2L ORF and the tricistronic construct was inserted
following the CMV promoter in the pcDNA 3.1/Zeo (þ) plasmid
(Fig. 1B). RK-13 cells were transfected and Zeocin was used for clonal
selection of cells. Western blotting was used to detect expression of
the VACV A2Flag protein with antibody to the Flag epitope and the
VACV A1 and G8 proteins with antibody to the picornavirus 2A
peptide in RK-G8-A1-A2Flag cell lysates (Fig. 1C). High molecular
weight bands may represent translational read through.
Confocal microscopy was used to determine the intracellular
location of the late transcription factors in RK-G8-A1-A2Flag cells.
In uninfected cells, the transcription factors were distributed
throughout the cytoplasm (Fig. 2, upper panel). However, when
the cells were infected with VACV, the transcription factors
apparently migrated into virus factories, which were revealed by
staining the DNA with DAPI or with antibody to the A14 mem-
brane protein, which was expressed from the viral genome (Fig. 2,
lower panels). The re-localization of all three factors was remark-
able and taken as an encouraging sign for their ability to function
with the viral RNA polymerase, although the mechanism for
sequestering the factors in the factory remains to be determined.
As proof of principal for our strategy, we infected normal RK-13
cells, RK13-A8/A23 cells and RK-G8-A1-A2Flag cells with vA23Δ and
transfected them with a plasmid encoding the F17 late protein or the
G8 intermediate protein under their natural promoters. UponWestern
blotting the F17 proteinwas detected in the RK-G8-A1-A2Flag cells but
not in the RK13-A8/A23 cells, whereas the opposite was true for the
G8 protein (Fig. 1D), conﬁrming the function and speciﬁcity of the
transcription factors and validating the system for our purpose.
Intermediate/late promoter screen
The previously classiﬁed 53 intermediate ORFs (Yang et al., 2011b)
were used as the starting point for the screen. None of these ORFs
were expressed in the presence of AraC indicating that they do not
have functional early promoters. However, the presence of late
promoter elements remained a possibility. Approximately 80 bp pre-
ceding each intermediate ORF was cloned adjacent to the Fireﬂy Luc
ORF. Both RK-G8-A1-A2Flag cells and RK-13 cells were infected with
vA23Δ and after 1 h were transfected with one of the VACV
intermediate promoter Fireﬂy LUC plasmids and with a control
plasmid encoding Renilla LUC adjacent to the HSV TK promoter for
normalization of transfection efﬁciency. After 16–18 h, LUC activities
were determined in the cell lysates. The non-speciﬁc Fireﬂy LUC values
in the RK-13 cells were subtracted from the values for the same
plasmids in the RK-G8-A1-A2Flag cells. The LUC activities varied in a
continuous fashion from very low to values approaching the strong
late F17 promoter (Bertholet et al., 1985), which was used as a positive
control (Fig. 3, Table 1). We calculated that 26 of the 53 intermediate
promoters had more than 5% of the F17 promoter activity.
Correlation of sequence features of intermediate promoters with late
promoter activity
Previous studies had pointed out signature features of late
promoters: speciﬁcally a TAAAT at the RNA start site frequently
Fig. 1. Construction and characterization of the RK-G8-A1-A2Flag cell line.
(A) Diagram depicting the assay to determine dual late promoter activity of
intermediate promoters. A cell that expresses the three late transcription factors
G8, A1 and A2, is infected with a VACV mutant with a deletion of the A23
intermediate transcription factor and is transfected with a plasmid containing LUC
regulated by a strict intermediate (I) promoter or by a dual intermediate/late (I/L)
promoter. Black circle indicates no LUC expression; yellow circle indicates
LUC expression. (B) Diagram of a tricistronic cassette regulated by a CMV promoter.
The picornavirus 2A-like sequences F2A and T2A separate the G8R and A1L ORFs
and the A1L and A2L ORFs, respectively. The A2L ORF has a C-terminal Flag tag.
(C) Western blots showing G8, A1 and A2 expression. A2 was detected with
antibody to the Flag epitope; G8 and A1 were detected with antibody to the
2A peptide. The positions of protein markers in kDa are shown on the left and the
A2, G8 and A1 bands on the right. (D) Expression of a late and intermediate gene.
RK-13, RK-G8-A1-A2Flag, or RK13-A8/A23 cells were infected with vA23Δ and
transfected with plasmids encoding the late F17R and intermediate G8R ORFs with
3XFlag tags regulated by their natural promoters. After 18 h, the cells were lysed
and analyzed by Western blotting with anti-Flag antibody. The single ﬂag epitope
on the A2 protein was not detected in the small amount of extract used for analysis
of the triple ﬂag on the F17 and G8 proteins.
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followed by a G and a T at 10 surrounded by several less conserved
Ts in the coding strand (Yang et al., 2011b). In contrast, promoters
thought to be primarily or exclusively intermediate frequently lacked
the T following the TAAA as well as the T at 10 but contained a more
AþT-rich sequence further upstream (Yang et al., 2011b). Here, we
identiﬁed sequence features of the intermediate promoters that
correlated with associated late activity. Most important were the
T at þ4, which follows the TAAA at the transcription start site, and
the T-content between 12 and 8. Individually the sequence
features and late promoter activity showed a moderate statistically
signiﬁcant correlation but together the correlation became strong
(Table 2). However, neither of those features correlated with
Fig. 2. Intracellular localization of transcription factors in RK-G8-A1-A2Flag cells. Uninfected RK-G8-A1-A2Flag cells (upper panel) and RK-G8-A1-A2 cells infected with
VACV for 7 h (lower panels) were ﬁxed and permeabilized. The samples were stained with a rabbit polyclonal primary antibody to the picornavirus 2A peptide, which
remains attached to the G8 and A1 proteins, a mouse anti-Flag MAb to detect FLAG attached to the A2 ORF and the mouse MAb to A14, followed by donkey anti rabbit IgG
and goat anti-mouse IgG coupled to Alexa Fluor 488 and Alexa Fluor 594, respectively. The nuclei and cytoplasmic viral factories (arrows) were stained with DAPI.
Fig. 3. Late activities of intermediate promoters. RK-A8-A1-A2Flag cells were infected with vA23Δ and transfected with plasmids encoding Fireﬂy LUC regulated by an
intermediate promoter. After 16 to 18 h, LUC activity was determined and normalized as described in Methods.
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intermediate promoter activity (Table 2), which was determined by
transfection of cells infected with VACV in the presence of AraC
(not shown). Intermediate promoter activity showed a moderate
statistically signiﬁcant correlation with A-content from 22 to 14
but neither A- nor T-content in this region correlated with late
transcription activity (Table 2). In addition, there was no signiﬁcant
correlation between the relative magnitudes of intermediate and late
promoter activities (not shown).
Mutational conﬁrmation of intermediate and late promoter
sequences
Our analyses suggested that distance from the transcriptional
start site and strand speciﬁcity for A and T residues, rather than
merely AþT DNA content, correlated with intermediate and late
promoter activities. To experimentally conﬁrm the sequence
correlations, we made mutations in promoters that are exclusively
or predominantly intermediate or late to convert them to the
opposite speciﬁcity. The promoter associated with the G8R ORF
was chosen as an example of a relatively strict intermediate
promoter (Table 1). Plasmids with green ﬂuorescence protein
(GFP) ORF adjacent to the wild type (WT) or mutated G8R
promoters were transfected into BS-C-1 cells that had been
infected with WT VACV in the presence and absence of AraC.
With the WT intermediate promoter there was similar GFP
synthesis under both conditions as expected (Fig. 4A). When the
sequence between residues 22 and 14 were mostly ﬂipped to
the complement (G8R-M1), however, GFP synthesis in the pre-
sence and absence of AraC was sharply reduced indicating loss of
intermediate promoter function despite retention of the AþT
Table 1
Dual late activities of intermediate promoters.
VACV WR VACV COP Relativea luminescence Functional categoriesb
33 K2L 22,623 Host interaction; EV and WV membrane proteins
35 K4L 21,103 DNA replication, core-associated enzymes and transcriptional factors
52 F13L 556,924 EV and WV membrane proteins
62 E6R 10,679 Required for morphogenesis
63 E7R 0 Unknown
64 E8R 826 Core-associated non-enzymatic proteins
67 E11L 74,499 Core-associated non-enzymatic proteins
69 O2L 249,648 Core-associated enzymes and transcriptional factors
69.5 O3L 55,201 MV membrane-associated proteins; EFC
70 I1L 54,568 Core-associated non-enzymatic proteins; required for morphogenesis; DNA-binding and packing proteins
74 I5L 151,740 MV membrane-associated proteins
75 I6L 33,651 Core-associated non-enzymatic proteins; required for morphogenesis; DNA-binding or packaging proteins
77 I8R 25,296 Core-associated enzymes and transcriptional factors; transcription
81 G4L 210,652 MV membrane-associated proteins; S-S bond formation pathway; required for morphogenesis
86 G8R 20,235 Transcription, late stage
91 L4R 174,828 Core-associated non-enzymatic proteins; DNA-binding proteins; transcription
93 J1R 61,879 Core-associated non-enzymatic proteins
99 H1L 79,812 Core-associated enzymes and transcriptional factors; transcription
101 H3L 120,648 MV membrane-associated proteins
105 H7R 19,760 Contributes to the formation of crescent membrane
111 D6R 74,841 Core-associated enzymes and transcriptional factors; DNA-binding and packing proteins; transcription
113 D8L 388 MV membrane-associated proteins
115 D10R 9701 Host interaction
116 D11L 45,394 Core-associated enzymes and transcriptional factors; Transcription
118 D13L 160,625 Required for morphogenesis; required for crescent formation
119 A1L 4072 Transcription, late stage
120 A2L 5502 Transcription, late stage
122 A3L 372,152 Core-associated non-enzymatic proteins; required for morphogenesis
125 A6L 54,180 Core-associated non-enzymatic proteins; required for morphogenesis
131 A12L 343,579 Core-associated non-enzymatic proteins
135 A15L 113,953 Core-associated non-enzymatic proteins; required for morphogenesis
136 A16L 8392 MV membrane-associated proteins; EFC
139 A19L 593,009 Unknown
142 A22R 67,366 DNA replication; DNA-binding or packing proteins
146 no ortholog 932 Pseudogene
147 no ortholog 0 Pseudogene
148 A25L 721,492 MV membrane-associated proteins; truncated
150 A27L 198,933 MV membrane-associated proteins
153 A30L 212,505 Core-associated non-enzymatic proteins; required for morphogenesis
153.5 A30.5L 0 Unknown
155 A32L 62,632 Core-associated enzymes and transcriptional factors; DNA-binding or packaging proteins
157 A34R 676,586 EV and WV membrane proteins
162 A38L 17,456 CD47-like putative membrane protein
164 no ortholog 0 Pseudogene
167 A42R 577,110 Unknown
168 A43R 26 Host interaction
179 A53R 506 Host interaction
186 B4R 21,721 Unknown
191 B9R 10,233 Unknown
192 B10R 0 Unknown
197 WR-B15R 134 Host interaction
206 C13L 2878 Unknown
204.5 No ortholog 112,865 Unknown
a Relative to activity (1,000,000 ﬂuorescent units) of F17 late promoter.
b EFC, Entry-Fusion Complex; EV, enveloped virion; WV, wrapped virion.
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content of the two DNA strands. As shown in Fig. 4A, the late
activity was enhanced by increasing the number of T residues
between 12 and 8 (G8R-M2) or removing one A in the TAAAAT
initiator sequence to make TAAAT (G8R-M3) and even more by
combining those mutations (G8R-M4). Nevertheless, these late
promoter up mutations did not increase GFP synthesis in the
presence of AraC, indicating no effect on intermediate promoter
activity.
The promoter associated with the late A14L ORF was used to
represent a strict late promoter. Plasmids with Flag-tagged A14L
ORF adjacent to WT or mutated promoters were transfected into
infected HeLa cells in the presence or absence of AraC. Under these
conditions, the WT A14L promoter showed faint activity in the
presence of AraC and strong activity in the absence of the drug,
consistent with a predominantly late promoter (Fig. 4B). When the
ﬁve Ts in the 12 to 8 region were ﬂipped to As (A14L-M1),
there was a dramatic decrease in A14 synthesis (Fig. 4B), again
showing the importance of strand speciﬁcity of the T and A
residues. When we modiﬁed the 22 to 14 region to make it
similar to the WT G8R promoter but left the original T-run from
12 to 8 (A14L-M2), synthesis increased in the presence of AraC
(Fig. 4B), indicating acquisition of intermediate promoter function.
Changing the T-run from 12 to 8 to A residues (A14L-M3) did
not decrease and appeared to slightly increase the intermediate
promoter activity as measured by A14 synthesis in the presence of
AraC. Thus, the sequences that correlated with late and inter-
mediate promoter activities were conﬁrmed experimentally.
Discussion
Poxviruses regulate gene expression by packaging the early
transcription system within the infectious virus particle and
sequentially synthesizing virus-encoded intermediate and late
transcription factors that collaborate with the virus-encoded
multisubunit DNA-dependent RNA polymerase and corresponding
promoter elements. Analysis of selected early, intermediate and
late transcripts demonstrated a strict regulation (Baldick and
Moss, 1993). However, we had noted that some intermediate
genes were expressed relatively more strongly in the absence
than in the presence of AraC, suggesting dual intermediate/late
promoters (Yang et al., 2011b). Here, we succeeded in dissecting
the promoter elements of hybrid promoters by employing a
mutant virus with a deletion of an intermediate transcription
factor gene and a stable cell line that expressed the three late
transcription factors. The dual late function of each intermediate
promoter was assessed by measuring LUC activity of a transfected
recombinant plasmid as an indirect measure of transcription. The LUC
activities varied in a continuous fashion from very low to values
approaching the strong late F17 promoter. Of 53 intermediate pro-
moters analyzed, we found that 26 had 5% or more of the late activity
of the strong F17R late promoter and some were nearly as strong.
However, we could not compare the relative intermediate and late
activities of individual dual promoters because of the different cell
lines and viruses used for the assays.
An important aspect of our work was the establishment of a cell
line that expressed all three late transcription factors. This was
accomplished using picornavirus 2A-like CHYSEL peptide sequences
that mediate co-translational separation of the nascent chains
(de Felipe and Ryan, 2004; Doronina et al., 2008). The ability to
simultaneously express three or more proteins from a single trans-
fected vector is an important advantage of this system. Although short
peptides remained at the C-termini of the G8 and A1 proteins, they did
not prevent functional activity and furthermore were used as epitope
Table 2
Correlation coefﬁcient analysis of promoter elements and promoter activities.
-22                     -14 -12         -8                   -1+1
NNNNNNNNNNNNNNNNNNNNNNNNNNNTAAANNNNN
Promoter elementsa Correlation with late promoter activities Correlation with intermediate promoter activities
Spearman rb P valuec Spearman rb P valuec
T following TAAA 0.56 o0.0001 0.01 0.9453
T content (12 to8) 0.45 0.001 0.01 0.9344
T content (12 to8)þT following TAAA 0.69 o0.0001 0.05 0.7579
A content (22 to 14) 0.11 0.4301 0.49 0.0004
a Coding strand nucleotides are shown.
b 0.00–0.19, very weak; 0.20–0.39, weak; 0.40–0.59, moderate; 0.60–0.79, strong; and 0.80–1.00, very strong.
c Po0.05 considered signiﬁcant.
Fig. 4. Mutational analyses of an intermediate and late promoter. (A) Intermediate
promoter mutations. The sequences of the WT G8R promoter and mutated G8R
promoters attached to GFP are shown. Plasmids containing these constructs were
transfected into cells that had been infected with VACV in the absence () or
presence (þ) of AraC. After 16 h, the cells were lysed and analyzed by Western
blotting with ﬂuorescent antibody to GFP. Relative band intensities shown below
the blot were determined using ImageJ. (B) Late promoter mutations. The WT A14L
promoter and mutated A14L promoters were attached to the A14L ORF with a Flag
tag. The sequences of the promoters are shown. Infection, transfection and Western
blotting were similar to that of panel A except that antibody to the Flag epitope
was used.
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tags with speciﬁc antibody. A remarkable feature of the RK-G8-A1-A2
cells was the relocation of the transcription factors upon VACV
infection. In uninfected cells, the factors were distributed throughout
the cytoplasm. However, upon infection, they localized within the viral
factories. Since this phenomenon was not the focus of our study, we
can only speculate as to how this might occur. Previous studies
demonstrated that the late transcription factors interact with each
other and with the H5 viral protein (Dellis et al., 2004; McCraith et al.,
2000). The interaction suggests that the H5 protein might be involved
in localization of the late transcription factors. H5 is a constitutively
expressed multifunctional nucleic acid binding protein involved in
post-replicative transcription and mRNA processing (Cresawn and
Condit, 2007; D'Costa et al., 2008; Kovacs and Moss, 1996), genome
replication (D'Costa et al., 2010) and virion morphogenesis (DeMasi
and Traktman, 2000). Moreover, biochemical and biophysical proper-
ties suggest that the H5 protein is intrinsically disordered and may be
a “hub” protein (Kay et al., 2013). Although the late transcription factor
cell line was successfully used to express reporter genes with late
promoters, we have been unable to use it for isolation of a VACV late
transcription factor deletion mutant. Whether the failure is due to
insufﬁcient amounts of the transcription factors or to other reasons is
unknown at this time.
Some features of VACV intermediate and late promoters were
previously recognized by sequence comparisons (Davison and Moss,
1989; Yang et al., 2011a, 2011b) and mutational analyses (Baldick et al.,
1992; Davison and Moss, 1989; Hirschmann et al., 1990; Knutson et al.,
2006). These studies led to the idea that VACV promoters have stage
speciﬁc core and initiator sequences separated by a spacer. By
correlating the late transcription activities of the intermediate pro-
moters, we found two statistically signiﬁcant features for late activity:
a T following TAAA at þ4 in the initiator region and T residues
between 12 and 8 in the core region of the coding DNA strand.
Neither of these features correlated with intermediate transcription
activity. On the other hand, the frequency of A residues from 22 to
14 correlated with intermediate transcription activity but not with
late transcription activity. The importance of the T-residue at þ4, to
form TAAAT, and the greater role of T-residues compared to A-residues
at 12 to 8 of late promoters had previously been recognized
(Davison and Moss, 1989), although at the time the distinction
between intermediate and late promoters had not been discovered.
A previous mutational study of G8R promoter also suggested the
importance of A-residues from 22 to 14 for intermediate promo-
ters (Baldick et al., 1992). In addition, interconversion of intermediate
and late promoters with TAAAT initiator sequences could be achieved
to some extent by changing the spacing between the core and initiator
sequences (Knutson et al., 2006). Here we demonstrated the impor-
tance of the A-content of the coding strand from 22 to 14 for
intermediate promoter activity and the T-content of the coding strand
between 12 and 8 for late promoter activity by transforming a
strict intermediate promoter into a late promoter and vice versa.
We also noted that some promoters classiﬁed as early based on
expression in the presence of a DNA synthesis inhibitor, have a
TAAA or TAAAT sequence near the start of the ORF suggesting
intermediate or late stage activity. Transfection studies with a
representative sample of such promoters suggested that many
have weak intermediate or late promoter activity but additional
work is needed to conﬁrm this (our unpublished data).
In principal, the utilization of three stages of transcription as well
as hybrid promoters enables poxviruses to ﬁne-tune the level and
duration of expression of individual genes. Previously, we compared
the biological roles of genes with early, intermediate and late
promoters. We now extended this analysis by comparing the inter-
mediate promoters with relatively low and high late promoter activity.
Since the late activities varied continuously (Fig. 3, Table 1), we used
an arbitrary value of 5% of the strong F17 late promoter to divide the
intermediate promoters into two groups. The rationale for 5% was that
half of the promoters were lower and half higher. The intermediate
genes encoding virion core and membrane proteins and proteins
involved in virion morphogenesis tended to have high late promoter
activity, whereas those involved in transcription and DNA replication
tended to have low or no late promoter activity (Fig. 5).
Materials and methods
Cells and viruses
RK-13 cells were grown in Dulbecco's minimum essential medium,
supplemented with 10% fetal bovine serum (FBS), 100 units of
penicillin and 100 mg of streptomycin per ml (Quality Biologicals,
Gaithersburg, MD). The medium for RK-G8-A1-A2Flag cells was
supplemented with 300 mg/ml Zeocin. The VACV deletion mutant
vA23Δwas propagated in a RK-13 cell line expressing the A8 and A23
intermediate transcription factors as previously described (Warren
et al., 2012).
Construction of the RK-G8-A1-A2Flag cell line
A G8-A1-A2Flag cassette separated by picornavirus 2A-like CHYSEL
peptide sequences was cloned in pcDNA 3.1/Zeo (þ) plasmid
Fig. 5. Gene functions of intermediate promoters with low and high late promoter activities. Intermediate promoters were divided into those with low o5% (striped) and
high 45% (black) of the activity of the late F17R promoter in the late promoter-speciﬁc transfection assay. The numbers of genes in each category are indicated.
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(Life Technologies, Grand Island, NY) as shown in Fig. 1B. The plasmid
was transfected into RK-13 cells using Lipofectamine 2000 (Life
Technologies) following the manufacturer's instructions. After 48 h,
the transfected cells were distributed to new ﬂasks at approximately
25% conﬂuence with fresh medium containing 750 mg/ml Zeocin. The
cells were fed with selective medium every 3 days until cell foci were
identiﬁed on day 10. The individual colonies were isolated with
cloning discs (Sigma Aldrich) and transferred to 96 well plates and
screened for Flag-epitope synthesis by Western blotting. The positive
colonies were put through a second phase of selection with 750 mg/ml
Zeocin. The established recombinant RK-G8-A1-A2Flag cell line was
grown as described above and supplemented with 300 mg/ml Zeocin
to maintain the selection pressure.
Plasmids, transfection, antibodies and western blotting
Recombinant plasmids were constructed by cloning PCR-ampliﬁed
target DNA fragments into Zero blunt TOPO vector (Life Technologies).
The inserted DNA was veriﬁed by sequencing. BS-C-1 cells were
transfected with plasmids and Lipofectamine 2000 (Life Technologies)
according to the manufacturer's instructions. The cells were lysed at
16–18 h after transfection. For Western blotting, proteins in cell lysates
were resolved by SDS polyacrylamide gel electrophoresis and trans-
ferred to nitrocellulose membranes using an iBlot apparatus (Life
Technologies). The membranes were blocked with 5% nonfat milk in
Tris-buffered saline with 0.05% Tween-20 for 1 h, incubated with
primary antibody for 1–2 h at room temperature or overnight at 4 1C,
washed with Tris-buffered saline with 0.05% Tween-20, incubated
with horseradish peroxidase-conjugated secondary antibody, washed
with Tris-buffered saline with 0.05% Tween-20 and developed using
chemiluminescent substrate (Pierce, Rockford, IL). Alternatively, a
ﬂuorescent secondary antibody was used and the signal was detected
with an Odyssey imaging system (LiCor). The band intensities were
determined with ImageJ (Wayne Rasband, Research Services Branch,
National Institute of Mental Health, Bethesda, MD). Rabbit anti-2A and
mouse anti-Flag M2 antibodies were purchased from Millipore (Bill-
erica, MA) and Agilent Technologies (Santa Clara, CA), respectively.
Mouse anti-A14MAbwas a gift from Dr. Yan Xiang (University of Texas
Health Science Center, TX).
LUC assays
Fireﬂy and Renilla LUC activities were measured simulta-
neously with a dual LUC assay system (Promega, Madison, WI)
according to the manufacturer's instruction. The transfection
efﬁciency for each experiment was normalized by expression of
a co-transfected Renilla LUC plasmid under HSV-TK promoter as
the internal control. Data were averaged from the results of
transfections performed in at least two independent experiments.
Intermediate and late LUC activities from different batches of
experiments were normalized by G8R and F17R promoter activity,
respectively.
Confocal microscopy
RK-G8-L1-L2Flag cells grown on coverslips were uninfected or
infected for 7 h and ﬁxed with 4% paraformaldehyde in phosphate
buffered saline (PBS) for 15 min at room temperature (RT) and
washed with PBS. The cells were permeabilized for 15 min with
0.1% Triton X-100 in PBS at RT and blocked with 10% FBS for
30 min. After blocking the cells were incubated with the primary
antibody in PBS containing 10% FBS for 1 h at RT. Cells were
washed and incubated with the secondary antibody conjugated to
dye (Molecular Probes, Eugene, OR) for 1 h. The coverslips were
washed and mounted on a glass slide by using prolong gold (Life
Technologies). Micrographs were acquired with a Leica TCS SP5
confocal inverted-base microscope with a 63 oil objective.
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